Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patimaporn Wongprompitak has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Naharuthai Inthasin

    Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    4 shared publications
  • Pattama Ekpo

    Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    3 shared publications
  • Pattama Ekpo

    Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    3 shared publications
  • Philippe Buchy

    Institut Pasteur du Laos, Ministry of Health, Vientiane P.O. Box 3560, Laos

    3 shared publications
  • Veasna Duong

    Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia

    3 shared publications
  • Wichittra Anukool

    Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand; Graduate Program in Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

    3 shared publications

Latest Publications

  • Open Access

    Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

    by Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi, Kulkanya Chokephaibulkit

    We evaluated the immunogenicity and reactogenicity of heterologous COVID-19 primary schedules involving BNT162b2 (Pfizer-BioNTech), ChAdOx1 nCoV-19 (AstraZeneca) and CoronaVac (Sinovac) in healthy adults, as well as booster response to BNT162b2 following heterologous CoronaVac and ChAdOx1 nCoV-19 regimens. Participants were randomized to one of seven groups that received two-dose homologous BNT162b2 or heterologous combinations of CoronaVac, ChAdOx1 nCoV-19 and BNT162b2, with 4 weeks interval. A total of 210 participants were enrolled, 30 in each group. Median age of participants was 38 (19–60) years, and 108/210 (51.43%) were female. Overall adverse events after the second dose were mild to moderate. We found that groups that received BNT162b2 as second dose induced the highest anti-receptor binding domain IgG response against the ancestral strain [BNT162b2: geometric mean concentration (GMC) 2133–2249 BAU/mL; ChAdOx1 nCoV-19: 851–1201; CoronaVac: 137–225 BAU/mL], neutralizing antibodies (NAb) against Beta and Delta, and interferon gamma response. All groups induced low to negligible NAb against Omicron after second dose. A BNT162b2 booster (third dose) following heterologous CoronaVac and ChAdOx1 nCoV-19 regimens induced >140-fold increase in NAb titers against Omicron. Our findings indicate that heterologous regimens using BNT162b2 as the second dose may be an alternative schedule to maximize immune response. While heterologous two-dose schedules induced low NAb against Omicron, the use of an mRNA vaccine booster dose substantially increased the Omicron response. These findings are relevant for low-income countries considering heterologous primary and booster COVID-19 vaccine schedules.


  • Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

    by Suvimol Niyomnaitham, Zheng Quan Toh, Paul Vincent Licciardi, Patimaporn Wongprompitak, Kanjana Srisutthisamphan, Katherine Kradangna Copeland, Kulkanya Chokephaibulkit


  • Open Access

    Molecular and Antifilarial IgG4 Detection Using the miniPCR-Duplex Lateral Flow Dipstick and BmSxp-ELISA in Myanmar Immigrant Communities

    by Patimaporn Wongprompitak, Navapon Kusuwan, Ladawan Khowawisetsut, Achinya Phuakrod, Duangnate Pipatsatitpong, Sirichit Wongkamchai

    Lymphatic filariasis (LF) is an important tropical disease that affects over a billion people in more than 80 countries and approximately 40 million people are currently suffering from severe disfigurement and disability. A diagnostic tool is the principal impact factor to determine the infection status of lymphatic filariasis. The purpose of the present study was to investigate nucleic acid of Wuchereria bancrofti as well as antifilarial IgG4 in a Myanmar immigrant community living along the Moei River, a natural border between Mae Sot, Tak province Thailand and Myawaddy, Myanmar which is an endemic area of bancroftian filariasis. Blood was collected from 300 Myanmar immigrants in Mae Sot district, Tak Province. The nucleic acid of W. bancrofti was assessed in the study population using our recent published miniPCR-Duplex Lateral Flow dipstick (DLFD) platform as well as the standard PCR technique. The antifilarial IgG4 was detected in the study population using the developed ELISA which used BmSxp protein as antigen. The miniPCR-DLFD method delivered results comparable to the standard PCR technique and it enables convenient and rapid visual detection of the parasite nucleic acid. Furthermore, the ELISA using BmSxp antigen demonstrated a sensitivity, specificity, and positive and negative predictive values of 98.1%, 98.9%, 96.3%, and 99.4% respectively. The W. bancrofti nucleic acid and antifilarial IgG4 were detected in 1.6% (5/300), and 2% (6/300) of the study population, accordingly. The results of this study also revealed important epidemiological data about LF on the Thai–Myanmar border.


  • Open Access

    Phylogenetic analysis of two new complete genomes of the hepatitis E virus (HEV) genotype 3 from Thailand

    by Tipsuda Chanmanee, Pravech Ajawatanawong, Suda Louisirirotchanakul, Watcharasak Chotiyaputta, Siwaporn Chainuvati, Patimaporn Wongprompitak

    Hepatitis E virus (HEV) is a causative agent of acute viral hepatitis globally. Evolutionary phylogeny classifies the HEV into eight genotypes that correlate with the viral transmission. Only four genotypes have been proven to be responsible for transmission in humans. However, there has been no report on the genomics and genotyping of HEV in Thailand during the past ten years. Here, we identified the genotype distributions of the Thai isolates of HEV and we sequenced two HEV genomes. We screened for 18 Thai isolates of HEV from Siriraj Hospital in Bangkok, from 2014–2016. The HEV genomes were sequenced from the serum and feces of a patient. The results showed that all Thai isolates of HEV were identified as genotype 3 (HEV-3). The ORF2 and genome phylogenies suggested two subgenotypes, called 3.1 and 3.2. The Thai isolates of HEV were frequently found in the subgenotype 3.1. The genome sequences of the two Thai isolates of HEV from the serum and fecal samples of the same patient showed 91% nucleotide similarity with the HEV genotype 3. Comparisons between the HEV genome and the ORF2 phylogenies illustrated that the ORF2 tree can be used to identify HEV genotypes, but it has less phylogenetic power for the HEV evolution. The two new genome sequences of HEV-3 from Thailand could contribute valuable information to the HEV genome study. (226 words)


  • Open Access

    Characterization of limbal explant sites: Optimization of stem cell outgrowth in in vitro culture

    by Pattama Ekpo, Naharuthai Inthasin, Sutthicha Matamnan, Patimaporn Wongprompitak, Methichit Wattanapanitch, Chawikan Boonwong, Chareenun Chirapapaisan, Panotsom Ngowyutagon, Mongkol Uiprasertkul, Pinnita Prabhasawat, et al.

    Simple limbal epithelial transplantation (SLET) and cultivated limbal epithelial transplantation (CLET) are proven techniques for treating limbal stem cell deficiency (LSCD). However, the precise regions that are most suitable for preparing explants for transplantation have not been identified conclusively. Accordingly, this in vitro study aimed at determining ideal sites to be selected for tissue harvest for limbal stem cell culture and transplantation. We evaluated cell outgrowth potential and the expression of stem cell markers in cultures from 48 limbal explants from five cadaveric donors. The limbal explants were generated from the three specific sites: Lcor (located innermost and adjacent to the cornea), Lm (middle limbus), and Lconj (located outermost adjacent to the conjunctiva). We found that explants from the Lconj and Lm sites exhibited higher growth potential than those from the Lcor site. Transcript encoding the stem cell marker and p63 isoform, ΔNp63, was detected in cells from Lm and Lconj explants; expression levels were slightly, though significantly (p-value < 0.05), higher in Lm than in Lconj, although expression of ΔNp63α protein was similar in cells from all explants. Differential expression of ATP-Binding Cassette Subfamily G Member 2 (ABCG2) did not reach statistical significance. Immunohistochemistry by indirect immunofluorescence analysis of limbus tissue revealed that the basal layer in explant tissue from Lconj and Lm contained markedly more stem cells than found in Lcor explant tissue; these findings correlate with a higher capacity for growth. Collectively, our findings suggest that explants from the Lconj and Lm sites should be selected for limbal cell expansion for both CLET and SLET procedures. These new insights may guide surgeons toward specific limbal sites that are most suitable for stem cell culture and transplantation and may ultimately improve treatment outcomes in the patients with LSCD.


  • Involvement of Toll-like receptor 2 on human corneal epithelium during an infection of Pythium insidiosum

    by Patimaporn Wongprompitak, Nawarat Pleewan, Wiwit Tantibhedhyangkul, Angkana Chaiprasert, Pinnita Prabhasawat, Naharuthai Inthasin, Pattama Ekpo

    Background: Pythium insidiosum , a pathogenic oomycete, is a common causative organism of infectious corneal ulcer. Studying the innate immune response at the ocular surface is important for better understanding of the underlying pathogenesis and host defense against P. insidiosum infection. Objective: The present study aims to investigate the role of Toll-like receptor (TLR)2 on human corneal epithelial cells (HCECs) in P. insidiosum infection. Methods: Human embryonic kidney (HEK) cells were stimulated with either P. insidiosum zoospores or hyphae. NF-kappa B activation was determined by spectrophotometric measurement of secreted embryonic alkaline phosphatase (SEAP) levels. The role of TLR2 in P. insidiosum infection was studied in HCECs and monocyte derived macrophages (MDMs) using anti-TLR2 neutralizing antibody. The expression levels of pro-inflammatory cytokines were determined. Results: Both P. insidiosum hypha and zoospore stimulated TLR2-dependent NF-kappa B activation in HEK-BlueTM-hTLR2 cells in dose-dependent manner. IL-6 and IL-8 , but not IL-1 beta, were upregulated in HCECs after stimulation with P. in-sidiosum . Blockade of TLR2 on HCECs altered neither IL-6 nor IL-8 expressions. In contrast, the 3 cytokines were upregulated in the stimulated MDMs and the expression levels of IL-1 beta and IL-8 but not IL-6 were attenuated in TLR2 blockade MDMs. Conclusion: P. insidiosum was recognized by human TLR2 on HEK cells. The mRNA expression levels of certain cyto-kines were dependent of TLR2 in P. insidiosum infected MDMs but not HCECs at early stage of infection.


  • Role of Toll-like receptor 2 in mediating the production of cytokines and human beta-defensins in oral mucosal epithelial cell response to Leptospiral infection

    by Naharuthai Inthasin, Patimaporn Wongprompitak, Chawikan Boonwong, Pattama Ekpo

    Background: Pathogenic Leptospira spp. is the causative agent of leptospirosis. Oral mucosal cavity is one of portal entry for this bacterium. Oral mucosal epithelium provides a physical barrier and secretes cytokines, chemokines and antimicrobial peptides (AMPs) in response to microbial infection. Human beta-defensins (hBDs); hBD1, hBD2, and hBD3 are predominantly AMPs expressed in the oral cavity. Toll-like receptors (TLRs) have been reported in hBD regulation. TLR2 recognizes leptospiral lipopolysaccharide, and plays a key role in the early control of leptospirosis. Objective: The aim of this study is to investigate the role of TLR2 in mediating the production of cytokines and hBDs in oral mucosal epithelial cell response to leptospiral infection. Methods: Cultivated oral mucosal epithelial cells were prepared, characterized, and compared with oral mucosal tissues. The TLRI-1O and hBD mRNA expressions were examined. Pro-inflammatory cytokine and hBD1-3 expressions in response to leptospires were determined by quantitative (q) RT-PCR. Results: The cultivated oral epithelium expressed TLR2 and hBD1-3. The induction of IL-1 beta, IL-8, TNF-alpha, and hBD2 were increased in response to Leptospira via TLR2 recognition. Conclusion: The characteristics of primary epithelial cells and tissue were similar in terms of TLR expression. All primary epithelial cells expressed TLR2 and hBD1-3. We used primary epithelial cells to study response to L. interrogans. Our results yielded the first evidence that human TLR2 regulates hBD2 expression in oral mucosa epithelial responded to L. interrogans.Expression of hBD2 may act to neutralize the virulence or prevent the invasion of L. interrogansat the portal of entry.


  • Effects of 1α,25 Dihydroxyvitamin D 3 on Pro‐inflammatory Cytokines of Palmitic Acid Treated Thp‐1 Cells

    by Annette D'ARqom, Voravich Luangwedchakarn, Pinklow Umrod, Patimaporn Wongprompitak, Wiwit Tantibhedyangkul

    The level of saturated fatty acids, such as palmitic acid (PA), correlates with chronic inflammation in obese and metabolic syndrome patients. However, low level of vitamin D 3 is observed in those conditions. The aim of this study is to investigate effects of 1α,25(OH) 2 D 3 on PA‐treated THP‐1 cells. Using quantitative real‐time polymerase chain reaction, we measure mRNA expression of pro‐inflammatory cytokines: TNF‐α, Interleukin (IL)‐1β, IL‐6, and chemokine IL‐8 under PA and 1α,25(OH) 2 D 3 influence. PA, at all concentrations (25–100 μM), enhanced LPS stimulatory effect on those mRNA expression compared to LPS‐treated and ‐untreated cells. Combination with 1α,25(OH) 2 D 3 increased cytokine expression at high (10 −6 M) and high‐normal (10 −8 M) concentrations compared to PA + LPS and LPS alone, both for 2 and 24 h. However, low‐normal (10 −10 M) and low (10 −12 M) levels of 1α,25(OH) 2 D 3 could not enhance PA effect, but mRNA expression of pro‐inflammatory cytokine was higher than LPS‐treated cells. Upstream pathway of 1α,25(OH) 2 D 3 , which is cholecalciferol, also gave the similar result. Further, inhibition of calcium pathway does not play a role in this mechanism. Thus, these findings support pro‐inflammatory effect of PA and vitamin D 3 on innate immune response, especially on fat‐induced inflammation. Practical Application: The effect of vitamin D 3 on chronic inflammation in obesity is uncertain. This study shows an in vitro possibility that vitamin D 3 could exaggerate inflammation when combined with high SFAs. The idea of using vitamin D 3 supplement to modulate inflammation in fat‐related inflammation needs further refined experiments before its clinical application.


  • Open Access

    Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial

    by Teerayuth Jiamjariyapon, Atiporn Ingsathit, Krit Pongpirul, Kotcharat Vipattawat, Suphattra Kanchanakorn, Akhathai Saetie, Duangjit Kanistanon, Patimaporn Wongprompitak, Vinai Leesmidt, Watcharapong Watcharasaksilp, et al.

    In developing countries, renal specialists are scarce and physician-to-patient contact time is limited. While conventional hospital-based, physician-oriented approach has been the main focus of chronic kidney disease (CKD) care, a comprehensive multidisciplinary health care program (Integrated CKD Care) has been introduced as an alternate intervention to delay CKD progression in a community population. The main objective is to assess effectiveness of Integrated CKD Care in delaying CKD progression. We carried out a community-based, cluster randomized controlled trial. Four hundred forty-two stage 3-4 CKD patients were enrolled. In addition to the standard treatments provided to both groups, the patients in the intervention group also received “Integrated CKD Care”. This was delivered by a multidisciplinary team of hospital staff in conjunction with a community CKD care network (subdistrict healthcare officers and village health volunteers) to provide group counseling during each hospital visit and quarterly home visits to monitor compliance with the treatment. Duration of the study was 2 years. The primary outcome was difference of mean eGFR between the intervention and the control groups over the study period. The mean difference of eGFR over time in the intervention group was significantly lower than the control group by 2.74 ml/min/1.73 m2 (95%CI 0.60–4.50, p = 0.009). Seventy composite clinical endpoints were reported during the study period with significantly different incidences between the control and the intervention groups (119.1 versus 69.4 per 1000 person-years; hazard ratio (HR) 0.59, 95% CI 0.4–0.9, p = 0.03). Integrated CKD Care can delay CKD progression in resource-limited settings. ( NCT01978951 ). Prospectively registered as of December 8, 2012.